Cliquez ici pour la version française | Click for English version
HPV Vaccination Programs in Sub-Saharan Francophone Africa: Preparation, Introduction, Restoration and Sustainability
6 and 7, December 2023 | Côte d’Ivoire, Abidjan
We are thrilled to announce that following the success of last year symposiums in East Africa – Ethiopia and in South Asia – New Delhi, the Coalition to Strengthen the HPV Immunization Community (CHIC) is expanding its horizons to Francophone Sub-Saharan Africa.
As part of our continued commitment to fostering a community of practice for the HPV vaccination program, we are organizing an in-person symposium in Abidjan, Côte d’Ivoire, on the 6th and 7th of December, 2023. This symposium, themed “Sub-Saharan Francophone Africa Symposium,” will centre around the vital aspects of HPV Vaccination Programs, emphasizing Preparation, Introduction, Restoration, and Sustainability.
We are extending an open invitation for the ‘Call for Abstracts,’ encouraging researchers and implementers from the region to contribute their expertise, findings, and experiences.
Dive deeper into the conversation, be part of the transformative dialogue, and let’s collectively drive forward the mission of cervical cancer elimination efforts.
Abstract submission guidelines
- Priority will be given to the abstracts from within Africa
- Abstracts should represent the original work or a project where the author was actively involved
- Informative abstracts and critical abstracts are accepted
- The Abstract should be written in English or French
- Abstract submissions that do not conform to the guidelines will not be accepted
- Abstract submissions received after the given deadline, due to any reason will not be accepted unless the deadline is extended
- The abstract should be submitted in the format of an MS Word (.doc or .docx) document
- The call has been extended and will now close on November 10, 2023.
The basic format for abstract
- The word limit for abstracts is 275 words
- Keywords should be provided as a must (no more than 6 words)
- Keywords should be written in lowercase letters (Not applicable to names/scientific names) and should be separated with commas
- Please do not include subheadings, bullets, lists and header/footer in the abstract
- Abstract titles should be short, but descriptive. Informative titles, indicating key points are encouraged. Abbreviations should not be used in the title
- Acronyms should be written in full the first time, mentioned in the text, followed by the abbreviation in parentheses
- When submitting your abstract, it is advised to adhere to the following structure: Introduction/Background, Methods, Results, Discussion, Conclusions, and/or Recommendations. However, this structure is not mandatory if it does not align with the nature of your abstract.
Abstract review process
Each abstract will be reviewed by at least 2 to 3 independent scientific reviewers according to the following six criteria:
- Relevance to the meeting objectives
- Background and rationale for the study/work
- Appropriateness of methods
- Presentation of results
- Conclusions and implication of results
- Public health significance
You will receive an email upon submission with a copy of the content that you submitted.
Disclaimer: Please note that the submission or submission confirmation via email does not mean that your submission is accepted. Our team will carefully review the abstract based on expertise and relevance for the meeting. Accepted abstracts will be notified by November 14th, 2023.
The submission period for abstracts is now officially closed. Thank you for your contributions! We will be sending out notifications regarding the outcomes on Monday, 14th of November. Stay tuned!